Platelet Count Affects Efficacy of Folic Acid in Preventing First Stroke
Xiangyi Kong(Capital Medical University), Yong Huo(Sun Yat-sen University), Xiaoshu Cheng(Nanchang University), Lishun Liu(China Agricultural University), Xianhui Qin(Nanfang Hospital), Fan Fan Hou(Southern Medical University), Yun Song(Novem (Netherlands)), Binyan Wang(Brigham and Women's Hospital), Ping Li(Nanchang University), Yan Zhang(Yukhnovskii Institute for Condensed Matter Physics of the National Academy of Sciences of Ukraine), Xiaobin Wang(Fujian University of Traditional Chinese Medicine), Jianping Li(Binzhou Medical University), Jingping Zhang(Central South University), Wenbin Yang(Chinese Academy of Agricultural Sciences), Richard Xu(Johns Hopkins University), Min Zhao, Benjamin Xu(Duke University), Yaren Yu(Nanfang Hospital), Xiao Huang(Wuhan Union Hospital), Genfu Tang(Anhui University), Shui‐Ping Zhao(Central South University)
Cited by 64
Related Papers
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
|The Lancet|2019|609
Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials
|The Lancet Diabetes & Endocrinology|2019|372